melatonin has been researched along with 1-methyl-4-phenylpyridinium in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 10 (76.92) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Baik, HH; Baik, HW; Cho, YH; Gwag, MR; Jeong, MY; Jin, BK; Joo, WS; Kim, YS; Shin, DY; Yoon, KS | 1 |
| Absi, E; Ayala, A; Machado, A; Parrado, J | 1 |
| Chen, ST; Chuang, JI; Hong, MH; Li, EI | 1 |
| Mohanakumar, KP; Thomas, B | 1 |
| Chen, TH; Chuang, JI | 1 |
| Bao, JF; Li, CL; Song, Y; Wu, RG; Zhang, XP | 1 |
| Chen, LJ; Gao, YQ; Li, XJ; Shen, DH; Sun, FY | 1 |
| Acuña-Castroviejo, D; Alvira, D; Camins, A; Folch, J; Pallas, M; Tajes, M; Verdaguer, E | 1 |
| Chetsawang, B; Chetsawang, J; Govitrapong, P | 2 |
| Chuang, JI; Hong, YT; Huang, JY | 1 |
| Chen, PC; Chuang, JI; Hsieh, CY; Huang, CY; Pan, IL; Shin, JW | 1 |
| Choi, H; Jung, YJ; Oh, E | 1 |
13 other study(ies) available for melatonin and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antioxidants; Dopamine; Dopamine Agents; Female; Male; Melatonin; Neurons; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra | 1998 |
Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Electron Transport Complex I; Humans; In Vitro Techniques; Melatonin; Mitochondria; Mitochondria, Liver; NADH, NADPH Oxidoreductases; Oxidative Stress; Oxygen Consumption; Parkinson Disease, Secondary; Rats; Synaptosomes | 2000 |
Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Dopamine; Glutathione; Immunohistochemistry; In Situ Nick-End Labeling; Male; Melatonin; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase | 2002 |
Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cell-Free System; Dopamine Agents; Dose-Response Relationship, Drug; Free Radical Scavengers; Glutathione; Hydrogen Peroxide; Hydroxyl Radical; Iron; Melatonin; Mice; Mice, Inbred BALB C; Mitochondria; Oxidative Stress; Substantia Nigra; Superoxide Dismutase | 2004 |
Effect of melatonin on temporal changes of reactive oxygen species and glutathione after MPP(+) treatment in human astrocytoma U373MG cells.
Topics: 1-Methyl-4-phenylpyridinium; Astrocytes; Dose-Response Relationship, Drug; Free Radical Scavengers; Glutathione; Humans; Melatonin; Reactive Oxygen Species; Time Factors | 2004 |
Melatonin attenuates 1-methyl-4-phenylpyridinium-induced PC12 cell death.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Death; Cell Survival; Culture Media, Serum-Free; Glucose; L-Lactate Dehydrogenase; Melatonin; Neuroprotective Agents; PC12 Cells; Rats; Tyrosine 3-Monooxygenase | 2005 |
Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Adjuvants, Immunologic; Animals; Brain; Brain Chemistry; Cell Death; DNA Damage; DNA, Mitochondrial; Dopamine Agents; Herbicides; Male; Melatonin; Mice; MPTP Poisoning | 2005 |
Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Calpain; Caspase 3; Caspases; Cell Survival; Cells, Cultured; Cerebellum; Cyclin-Dependent Kinase 5; Enzyme Activation; Melatonin; Nerve Tissue Proteins; Neurons; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2006 |
Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Line, Tumor; Cytoprotection; Humans; JNK Mitogen-Activated Protein Kinases; Melatonin; Phosphorylation; Signal Transduction | 2007 |
Protection against cell death and sustained tyrosine hydroxylase phosphorylation in hydrogen peroxide- and MPP-treated human neuroblastoma cells with melatonin.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Blotting, Western; Cell Death; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Desipramine; Humans; Hydrogen Peroxide; Melatonin; Neuroblastoma; Phosphorylation; Tyrosine 3-Monooxygenase | 2009 |
Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Antibodies; Cell Death; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 9; Fibroblast Growth Factors; Glial Fibrillary Acidic Protein; Herbicides; Male; Melatonin; Mesencephalon; Microtubule-Associated Proteins; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Tetrazolium Salts; Thiazoles; Time Factors; Tyrosine 3-Monooxygenase | 2009 |
Melatonin prevents the dynamin-related protein 1-dependent mitochondrial fission and oxidative insult in the cortical neurons after 1-methyl-4-phenylpyridinium treatment.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cerebral Cortex; Dynamins; Melatonin; Mitochondrial Dynamics; MPTP Poisoning; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2016 |
Melatonin attenuates MPP
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Cell Line, Tumor; Dopaminergic Neurons; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Melatonin; Neuroblastoma; Parkinson Disease | 2022 |